Watch Demo

Australia Lipid Modifying Drug Industry Outlook 2022 - 2026

See how Australia Lipid Modifying Drug performed compared to key markets such as South Korea, Spain and Italy.

Key Market Indicators

Sales of lipid-modifying medicines in Australia are set to plummet 11.3% per year, on average, to $195 million by 2026. This follows a 5.6% year-on-year decline since 1995. Australia was the sixth-largest market for these medicines in 2021, with sales of $400 million. Canada overtook it in 2021, with sales of $395 million. Spain, Italy and Germany ranked second, third and fourth, respectively.

Marketing Banner

Australia Lipid Modifying Drug Market Data and Forecasts

How much will Australia Lipid Modifying Drug Market grow to 2026?

Forecast: Lipid Modifying Medicine Sales in Australia
Forecast: Lipid Modifying Medicine Sales in Australia
Forecast: Lipid Modifying Medicine Sales in Australia
Forecast: Lipid Modifying Medicine Use in Australia
Forecast: Lipid Modifying Medicine Sales in Australia
More in Lipid Modifying Drug Industry for 2028